What does Guizhou Yibai Pharmaceutical Co., Ltd. do?

Guizhou Yibai Pharmaceutical Co., Ltd. (600594.SS) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 600594.SS's market cap?

Guizhou Yibai Pharmaceutical Co., Ltd. (600594.SS) has a market capitalization of approximately $3.23 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does 600594.SS pay a dividend?

Yes — Guizhou Yibai Pharmaceutical Co., Ltd. (600594.SS) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.

Is 600594.SS profitable?

Guizhou Yibai Pharmaceutical Co., Ltd. (600594.SS) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

600594.SS

Guizhou Yibai Pharmaceutical Co., Ltd.

SHH·Drug Manufacturers, Specialty & Generic · Healthcare

¥4.08¥0.24+6.25%

Market cap¥3.23B·Market closed·Aug 26 7:00 AM UTC

Price Chart

¥4.08+¥0.24 (+6.25%)today

−21.24%CAGR −4.66%

Select date range

FromTo

Mar 23, 2004Aug 26, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)0.00%

Annual Dividend (FWD)¥0.00

Dividend Growth (5Y)—

Dividend Safety—

Payout Ratio—

FCF Payout Ratio—

Most Recent Dividend¥0.066

Ex-Dividend DateJun 7

Payment DateJun 7

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report DateMar 31

Reported vs Estimate−¥0.01

Earnings Surprise—

FinancialsFinancials Tab

Revenue¥1.56B

Net Income−¥390.00M

Net Margin−25.0%

Operating Cash Flow¥150.49M

Capital Expenditures¥34.84M

Free Cash Flow¥115.66M

Return on Equity−18.5%

Return on Invested Capital−1.6%

Net Debt¥197.05M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 600594.SS and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 600594.SS's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 600594.SS and 80,000+ other tickers.

About Guizhou Yibai Pharmaceutical Co., Ltd.

Guizhou Yibai Pharmaceutical Co., Ltd. is a Chinese pharmaceutical enterprise that encompasses the full spectrum of activities from researching and developing new drugs to their production and commercialization throughout the country. The company offers a diverse portfolio of medications, available in various dosage forms including capsules, tablets, granules, syrups, liquid injectables (small-volume), lyophilized powder injections, traditional pills, and oral solutions. These therapeutic agents are designed to address a broad range of medical conditions, specifically targeting oncology…

CEO: Ya Qi Dou
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Exchange: SHH
Employees: 4,832
Website: www.gzcci.com

Peers

Peers Tab

002864.SZ

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd

Cap

¥3.1B

000788.SZ

PKU HealthCare Corp.,Ltd.

Cap

¥3.4B

300239.SZ

Baotou Dongbao Bio-Tech Co.,Ltd

Cap

¥3.1B

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 600594.SS

What does Guizhou Yibai Pharmaceutical Co., Ltd. do?: Guizhou Yibai Pharmaceutical Co., Ltd. (600594.SS) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 600594.SS's market cap?: Guizhou Yibai Pharmaceutical Co., Ltd. (600594.SS) has a market capitalization of approximately $3.23 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does 600594.SS pay a dividend?: Yes — Guizhou Yibai Pharmaceutical Co., Ltd. (600594.SS) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.
Is 600594.SS profitable?: Guizhou Yibai Pharmaceutical Co., Ltd. (600594.SS) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.